Global Amniotic Membrane Market Insights Forecasts to 2033

• The Global Amniotic Membrane Market Size was Valued at USD 1.68 Billion in 2023
• The Market Size is Growing at a CAGR of 7.86% from 2023 to 2033
• The Worldwide Amniotic Membrane Market Size is Expected to Reach USD 3.58 Billion by 2033
• Asia Pacific is Expected to Grow the fastest during the forecast period.

The Global Amniotic Membrane Market Size is Anticipated to Exceed USD 3.58 Billion by 2033, Growing at a CAGR of 7.86% from 2023 to 2033.   

Market Overview

The thin, flexible tissue that borders the amniotic sac during pregnancy is called the amniotic membrane. It provides vital nutrients and development hormones while enclosing and preserving the growing fetus. Due to its capacity to promote healing and regenerative qualities, it can be used for medical treatments and procedures during childbirth. Due to the amniotic membrane having special qualities, it is widely utilized to treat various eye surface diseases and injuries. The primary factor driving demand for amniotic membranes is their therapeutic potential in different medical applications, including tissue regeneration, ophthalmology, and wound healing. The rising incidence of burn injuries, and eye disorders, and the rising need for wound care biologics are driving the rapid growth of the amniotic membrane market. The growing prevalence of chronic wounds, developments in tissue engineering and biotechnology, and growing consumer acceptance and knowledge of amniotic membrane products are all driving the growth in the amniotic membrane market.       

Report Coverage

This research report categorizes the amniotic membrane market based on various segments and regions forecasts revenue growth and analyzes trends in each submarket. The report analyses the key growth drivers, opportunities, and challenges influencing the amniotic membrane market. Recent market developments and competitive strategies such as expansion, type launch, development, partnership, merger, and acquisition have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key market players and analyses their core competencies in each sub-segment of the amniotic membrane market.

Driving Factors

The increasing demand for amniotic membrane products in the treatment of pressure ulcers, venous leg ulcers, and diabetic foot ulcers, among other chronic wounds. One of the main factors propelling the growth of frozen amniotic membranes is their increasing application, particularly in the medical and surgical fields. The demand for these tissue-based products and the number of transplants has increased as a result of the greater awareness, which also motivated additional contributions and drove the growth of the amniotic membrane market. Research developments in stem cell and regenerative medicine, higher R&D spending, and an increase in surgeries performed worldwide are all factors that are driving the growth of the amniotic membrane market.     

Restraining Factors

The high expense of amniotic membrane therapy is possibly restraining market growth. Moreover, the market is being restricted by the infection risk associated with the application of amniotic membranes.    

Market Segmentation

The amniotic membrane market share is classified into product, application, and end-user.  

• The cryopreserved segment is estimated to hold the largest market revenue share through the projected period.  

Based on the product, the amniotic membrane market is classified into cryopreserved and lyophilized. Among these, the cryopreserved segment is estimated to hold the largest market revenue share through the projected period. Due to its special qualities, cryopreserved amniotic membrane (CAM) is widely used in many different medical specialties. Pressure sores, venous leg ulcers, and diabetic foot ulcers all be successfully treated with cryopreserved amniotic membrane (CAM).  

• The ophthalmology segment is anticipated to hold the largest market share through the forecast period.

Based on the application, the amniotic membrane market is divided into surgical wounds, ophthalmology, and others. Among these, the ophthalmology segment is anticipated to hold the largest market share through the forecast period. In ophthalmology, amniotic membrane transplantation (AMT) is used to treat a variety of ocular surface conditions. The need for improved treatment options in ophthalmology is being driven by the rising occurrence of ocular surface disorders, such as pterygium, corneal ulcers, and dry eye diseases, which are brought on by aging populations and an increase in ocular damage.   

• The hospital segment is anticipated to hold the largest market share through the forecast period.

Based on the end user, the amniotic membrane market is divided into hospitals, ambulatory surgical centers (ASCs), specialty clinics, research and academic institutes, and others. Among these, the hospital segment is anticipated to hold the largest market share through the forecast period. The need for cutting-edge and efficient treatment choices to improve patient outcomes is driving an increase in hospital demand, highlighting the crucial role amniotic membranes play in modern medical care.  

Regional Segment Analysis of the Amniotic Membrane Market

• North America (U.S., Canada, Mexico) 
• Europe (Germany, France, U.K., Italy, Spain, Rest of Europe)
• Asia-Pacific (China, Japan, India, Rest of APAC)
• South America (Brazil and the Rest of South America) 
• The Middle East and Africa (UAE, South Africa, Rest of MEA)

North America is anticipated to hold the largest share of the amniotic membrane market over the predicted timeframe.

North America is anticipated to hold the largest share of the amniotic membrane market over the predicted timeframe. Two major factors boosting market growth are North America are growing focus on regenerative medicine and its quick adoption of cutting-edge technologies. The region expansion is further supported by notable advancements in the preservation and application of amniotic membranes for eye and wound care therapies. The market growth in this region is also helped by supportive regulatory frameworks and ongoing investments in research & development.   

Asia Pacific is expected to grow at the fastest CAGR growth of the amniotic membrane market during the forecast period. China and Japan are expected to dominate the Asia-Pacific market. Moreover, the availability of qualified experts and the presence of developing healthcare facilities are likely to fuel market growth in this region. In addition, the growing knowledge of the advantages provided by amniotic membranes is probably going to drive growth in the Asia Pacific region.   

Europe is anticipated to hold a significant share of the amniotic membrane market over the predicted timeframe. Europe has a publicly funded healthcare system, and some nations have implemented universal healthcare policies, which has increased demand for the products. Healthcare providers in this region should use amniotic membranes more frequently as the number of patients with chronic illnesses rises.   

Competitive Analysis:

The report offers the appropriate analysis of the key organizations/companies involved within the amniotic membrane market along with a comparative evaluation primarily based on their type of offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes type development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.

List of Key Companies

• BioTissue Holdings Inc.
• NovaBay Pharmaceuticals, Inc.
• Xtant Medical Holdings, Inc.
• Amnio Technology, LLC
• Applied Biologics LLC
• Celularity Inc.
• Tissue-Tech Inc.
• Corza Health, Inc.
• Integra LifeSciences Holdings Corporation
• MiMedx Group, Inc.
• DermaSciences
• Organogenesis Holdings Inc.
• Skye Biologics, Inc.
• Smith & Nephew plc
• Others  

Key Target Audience

• Market Players
• Investors
• End-users
• Government Authorities 
• Consulting And Research Firm
• Venture capitalists
• Value-Added Resellers (VARs)

Recent Developments

• In June 2024, A novel, hydrated, shelf-stable cryopreserved amniotic membrane (CAM) solution called CAM360 AmnioGraft (CAM360 AG) was launched by BioTissue to treat ocular surface diseases and disorders. According to a news release, the treatment is perfect for individuals with mild to moderate dry eye disease (DED) and other ocular surface disorders, striving to maximize their comfort.   

• In December 2023, the use of amniotic membranes in eyecare teaching could be helped by the collaboration between Woo University and NovaBay Pharmaceuticals, Inc. (NYSE American: NBY).  

Market Segment

This study forecasts revenue at global, regional, and country levels from 2023 to 2033. Spherical Insights has segmented the amniotic membrane market based on the below-mentioned segments: 

Global Amniotic Membrane Market, By Product

• Cryopreserved
• Lyophilized   

Global Amniotic Membrane Market, By Application

• Surgical Wounds
• Ophthalmology
• Others

Global Amniotic Membrane Market, By End User  

• Hospitals
• Ambulatory Surgical Centers (ASCs)
• Specialty Clinics
• Research and Academic Institutes
• Others

Global Amniotic Membrane Market, By Regional Analysis

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Rest of Asia Pacific
• South America
  • Brazil
  • Argentina
  • Rest of South America
• Middle East & Africa
  • UAE
  • Saudi Arabia
  • Qatar
  • South Africa
  • Rest of the Middle East & Africa